Abstract
Journal search link (https://majms.alkafeel.edu.iq/journal/vol1/iss1/4/)
A drug that is administered through a catheter into the bladder is referred to as an intravesical drug delivery system.
The aim of this work is to improvise intravesical drug delivery of Tacrolimus loaded lipid polymer hybrid nanoparticles
thermosensitive gel for bladder wall to provide control release, increase intravesical residence time and avoid fast
removal by urination. The Tacrolimus loaded lipid polymer hybrid nanoparticles mimic cell membrane and enhance
cellular uptakes. Our data reveals nanocarrier formation with a mean particle size, zeta potential and entrapment efficiency of optimal formula was found to be 124 ± 0.01 nm,-27.5 ± 0.102mv and 72% ± 0.15% respectively. In situ gelling
formulations containing TACeCSeLPHNs can adhere to the mucosal layer of the bladder and help in the diffusion of
therapeutic agent across the bladder wall. To impart mechanical strength and mucoadhesive properties, the chitosan
concentration was adjusted to 0.5% and 0.25%.The image of field emission scanning electron microscope shows an
irregular surface with filled pores with nanoparticles. The gel was syringeable and had reasonable viscosity within room
temperature. A Tissue uptake study reveals that Tacrolimus loaded lipid polymer hybrid nanoparticles have been
penetrating bladder tissues and accumulated inside the cytoplasm and nucleus of urothelium epithelial cells. In addition, the bioimaging study shows that the gel resided inside the bladder for up to 2 h and completely urinated out of the
bladder with negligible distribution to other tissues.
A drug that is administered through a catheter into the bladder is referred to as an intravesical drug delivery system.
The aim of this work is to improvise intravesical drug delivery of Tacrolimus loaded lipid polymer hybrid nanoparticles
thermosensitive gel for bladder wall to provide control release, increase intravesical residence time and avoid fast
removal by urination. The Tacrolimus loaded lipid polymer hybrid nanoparticles mimic cell membrane and enhance
cellular uptakes. Our data reveals nanocarrier formation with a mean particle size, zeta potential and entrapment efficiency of optimal formula was found to be 124 ± 0.01 nm,-27.5 ± 0.102mv and 72% ± 0.15% respectively. In situ gelling
formulations containing TACeCSeLPHNs can adhere to the mucosal layer of the bladder and help in the diffusion of
therapeutic agent across the bladder wall. To impart mechanical strength and mucoadhesive properties, the chitosan
concentration was adjusted to 0.5% and 0.25%.The image of field emission scanning electron microscope shows an
irregular surface with filled pores with nanoparticles. The gel was syringeable and had reasonable viscosity within room
temperature. A Tissue uptake study reveals that Tacrolimus loaded lipid polymer hybrid nanoparticles have been
penetrating bladder tissues and accumulated inside the cytoplasm and nucleus of urothelium epithelial cells. In addition, the bioimaging study shows that the gel resided inside the bladder for up to 2 h and completely urinated out of the
bladder with negligible distribution to other tissues.